Force requirements and insulin delivery profiles of four injection devices

Kenichi Toraishi, Yoichi Yuizono, Noriko Nakamura, Shino Kato, Tsuyoshi Aoki, Kenji Ashida, Yasuhiro Sako

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Injection force requirements for four insulin pen-type injection devices were evaluated using the AGS-IkNG Autograph force measurement device (Shimadzu Corp., Kyoto, Japan). Results: Compared with the Humulin® Pen (the Japanese brand name is Humacart® kit; the same device as the Humalog® Pen; Eli Lilly, Indianapolis, IN), HumaPen® Ergo (Eli Lilly), and NovoPen® 3 (Novo Nordisk A/S, Bagsvaerd, Denmark), the InnoLet® (Novo Nordisk) required the lowest injection force to both initiate piston movement and commence insulin delivery and required the lowest overall force throughout delivery. InnoLet and NovoPen 3 showed the most even load-displacement curves, suggesting a smoother delivery of insulin during injection. In contrast, the Humulin Pen and HumaPen Ergo demonstrated marked fluctuations in the force required to complete injection. Conclusions: These performance characteristics appeared consistent with mechanical features of these insulin delivery devices, and the results highlight the potential importance of careful pen selection for patients with neuromuscular weakness or impaired manual coordination.

Original languageEnglish
Pages (from-to)629-635
Number of pages7
JournalDiabetes Technology and Therapeutics
Volume7
Issue number4
DOIs
Publication statusPublished - Aug 1 2005

Fingerprint

Insulin
Equipment and Supplies
Insulin, Regular, Human
Injections
Insulin Lispro
Denmark
Patient Selection
Names
Japan

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this

Toraishi, K., Yuizono, Y., Nakamura, N., Kato, S., Aoki, T., Ashida, K., & Sako, Y. (2005). Force requirements and insulin delivery profiles of four injection devices. Diabetes Technology and Therapeutics, 7(4), 629-635. https://doi.org/10.1089/dia.2005.7.629

Force requirements and insulin delivery profiles of four injection devices. / Toraishi, Kenichi; Yuizono, Yoichi; Nakamura, Noriko; Kato, Shino; Aoki, Tsuyoshi; Ashida, Kenji; Sako, Yasuhiro.

In: Diabetes Technology and Therapeutics, Vol. 7, No. 4, 01.08.2005, p. 629-635.

Research output: Contribution to journalArticle

Toraishi, K, Yuizono, Y, Nakamura, N, Kato, S, Aoki, T, Ashida, K & Sako, Y 2005, 'Force requirements and insulin delivery profiles of four injection devices', Diabetes Technology and Therapeutics, vol. 7, no. 4, pp. 629-635. https://doi.org/10.1089/dia.2005.7.629
Toraishi, Kenichi ; Yuizono, Yoichi ; Nakamura, Noriko ; Kato, Shino ; Aoki, Tsuyoshi ; Ashida, Kenji ; Sako, Yasuhiro. / Force requirements and insulin delivery profiles of four injection devices. In: Diabetes Technology and Therapeutics. 2005 ; Vol. 7, No. 4. pp. 629-635.
@article{5d09d5f91b88464d9e41e057c4e1f25e,
title = "Force requirements and insulin delivery profiles of four injection devices",
abstract = "Background: Injection force requirements for four insulin pen-type injection devices were evaluated using the AGS-IkNG Autograph force measurement device (Shimadzu Corp., Kyoto, Japan). Results: Compared with the Humulin{\circledR} Pen (the Japanese brand name is Humacart{\circledR} kit; the same device as the Humalog{\circledR} Pen; Eli Lilly, Indianapolis, IN), HumaPen{\circledR} Ergo (Eli Lilly), and NovoPen{\circledR} 3 (Novo Nordisk A/S, Bagsvaerd, Denmark), the InnoLet{\circledR} (Novo Nordisk) required the lowest injection force to both initiate piston movement and commence insulin delivery and required the lowest overall force throughout delivery. InnoLet and NovoPen 3 showed the most even load-displacement curves, suggesting a smoother delivery of insulin during injection. In contrast, the Humulin Pen and HumaPen Ergo demonstrated marked fluctuations in the force required to complete injection. Conclusions: These performance characteristics appeared consistent with mechanical features of these insulin delivery devices, and the results highlight the potential importance of careful pen selection for patients with neuromuscular weakness or impaired manual coordination.",
author = "Kenichi Toraishi and Yoichi Yuizono and Noriko Nakamura and Shino Kato and Tsuyoshi Aoki and Kenji Ashida and Yasuhiro Sako",
year = "2005",
month = "8",
day = "1",
doi = "10.1089/dia.2005.7.629",
language = "English",
volume = "7",
pages = "629--635",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Force requirements and insulin delivery profiles of four injection devices

AU - Toraishi, Kenichi

AU - Yuizono, Yoichi

AU - Nakamura, Noriko

AU - Kato, Shino

AU - Aoki, Tsuyoshi

AU - Ashida, Kenji

AU - Sako, Yasuhiro

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Background: Injection force requirements for four insulin pen-type injection devices were evaluated using the AGS-IkNG Autograph force measurement device (Shimadzu Corp., Kyoto, Japan). Results: Compared with the Humulin® Pen (the Japanese brand name is Humacart® kit; the same device as the Humalog® Pen; Eli Lilly, Indianapolis, IN), HumaPen® Ergo (Eli Lilly), and NovoPen® 3 (Novo Nordisk A/S, Bagsvaerd, Denmark), the InnoLet® (Novo Nordisk) required the lowest injection force to both initiate piston movement and commence insulin delivery and required the lowest overall force throughout delivery. InnoLet and NovoPen 3 showed the most even load-displacement curves, suggesting a smoother delivery of insulin during injection. In contrast, the Humulin Pen and HumaPen Ergo demonstrated marked fluctuations in the force required to complete injection. Conclusions: These performance characteristics appeared consistent with mechanical features of these insulin delivery devices, and the results highlight the potential importance of careful pen selection for patients with neuromuscular weakness or impaired manual coordination.

AB - Background: Injection force requirements for four insulin pen-type injection devices were evaluated using the AGS-IkNG Autograph force measurement device (Shimadzu Corp., Kyoto, Japan). Results: Compared with the Humulin® Pen (the Japanese brand name is Humacart® kit; the same device as the Humalog® Pen; Eli Lilly, Indianapolis, IN), HumaPen® Ergo (Eli Lilly), and NovoPen® 3 (Novo Nordisk A/S, Bagsvaerd, Denmark), the InnoLet® (Novo Nordisk) required the lowest injection force to both initiate piston movement and commence insulin delivery and required the lowest overall force throughout delivery. InnoLet and NovoPen 3 showed the most even load-displacement curves, suggesting a smoother delivery of insulin during injection. In contrast, the Humulin Pen and HumaPen Ergo demonstrated marked fluctuations in the force required to complete injection. Conclusions: These performance characteristics appeared consistent with mechanical features of these insulin delivery devices, and the results highlight the potential importance of careful pen selection for patients with neuromuscular weakness or impaired manual coordination.

UR - http://www.scopus.com/inward/record.url?scp=23944432922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944432922&partnerID=8YFLogxK

U2 - 10.1089/dia.2005.7.629

DO - 10.1089/dia.2005.7.629

M3 - Article

C2 - 16120038

AN - SCOPUS:23944432922

VL - 7

SP - 629

EP - 635

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 4

ER -